Literature DB >> 907393

A rational approach to the surgical management of melanoma.

E C Holmes, H S Moseley, D L Morton, W Clark, D Robinson, M M Urist.   

Abstract

Our experience with 294 regional lymph node dissections in 250 patients are reviewed. The relationship between the Clark's level of invasion and the thickness of the primary is related to regional lymph node metastases. Patients with Clark's Level III melanoma had a 29% incidence of regional lymph node metastases, Clark's Level IV had a 42% incidence of regional lymph node metastases and Clark's Level V a 58% incidence of regional lymph node metastases. Primary melanomas greater than 1.5 mm in thickness had a 38% incidence of positive regional lymph nodes. We therefore recommend a regional lymphadenectomy in patients with Clark's Levels III, IV and V and all melanomas that are greater than 1.5 mm in thickness. A new technique is described which is helpful in localizing the direction of ambiguous lymphatic drainage in patients with truncal melanoma. The use of radioactive colloidal gold scanning has been useful in predicting lymphatic shed in these ambiguous truncal melanomas. Certain technical aspects of inguinal lymph node dissection are emphasized in an attempt to reduce the morbidity of these dissections. It is emphasized that iliac-obturator lymph node dissections are not performed unless the inguinal lymph nodes are found to be involved by frozen section examination at the time of surgery.

Entities:  

Mesh:

Year:  1977        PMID: 907393      PMCID: PMC1396278          DOI: 10.1097/00000658-197710000-00010

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  14 in total

1.  PROGNOSIS IN MALIGNANT MELANOMA.

Authors:  G MACNEER; T DASGUPTA
Journal:  Surgery       Date:  1964-09       Impact factor: 3.982

2.  RESULTS OF GROIN DISSECTION FOR MALIGNANT MELANOMA IN 220 PATIENTS.

Authors:  J G FORTNER; R J BOOHER; G T PACK
Journal:  Surgery       Date:  1964-04       Impact factor: 3.982

3.  Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck.

Authors:  M G Hansen; A B McCarten
Journal:  Am J Surg       Date:  1974-10       Impact factor: 2.565

4.  Results of regional lymph node dissection for melanoma.

Authors:  S L Gumport; M N Harris
Journal:  Ann Surg       Date:  1974-01       Impact factor: 12.969

5.  The role of groin dissection in the management of melanoma of the lower extremity.

Authors:  J G McCarthy; C D Haagensen; F P Herter
Journal:  Ann Surg       Date:  1974-02       Impact factor: 12.969

6.  Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1975-11       Impact factor: 12.969

7.  Regional lymph node metastases and the level of invasion of primary melanoma.

Authors:  E C Holmes; W Clark; D L Morton; F R Eilber; A J Bochow
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

8.  Course and treatment results of young patients with carcinoma of the pancreas.

Authors:  P R Jochimsen; N W Pearlman; R L Lawton
Journal:  Surg Gynecol Obstet       Date:  1977-01

9.  Comparison of lymphedema following incontinuity and discontinuity groin dissection.

Authors:  D Papachristou; J G Fortner
Journal:  Ann Surg       Date:  1977-01       Impact factor: 12.969

10.  The accuracy of predicting lymph nodes metastases in malignant melanoma by clinical examination and microstaging.

Authors:  L I Goldman; W H Clark; E A Bernardino; A M Ainsworth
Journal:  Ann Surg       Date:  1976-11       Impact factor: 12.969

View more
  26 in total

1.  Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer.

Authors:  Allan W Silberman; Carie McVay; Jason S Cohen; Jack F Altura; Sandra Brackert; Gregory P Sarna; Daphne Palmer; Albert Ko; Leslie Memsic
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

Review 2.  Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute.

Authors:  Sanjay P Bagaria; Mark B Faries; Donald L Morton
Journal:  J Surg Oncol       Date:  2010-06-15       Impact factor: 3.454

Review 3.  Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma.

Authors:  Donald L Morton
Journal:  Clin Exp Metastasis       Date:  2012-06-24       Impact factor: 5.150

Review 4.  Surgery and sentinel lymph node biopsy.

Authors:  Mark B Faries; Donald L Morton
Journal:  Semin Oncol       Date:  2007-12       Impact factor: 4.929

5.  Frequency of occult residual melanoma after excision of a clinically positive regional lymph node.

Authors:  M Kane; E McClay; R E Bellet
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

Review 6.  Combined modality therapy of malignant melanoma.

Authors:  E M Hersh; J U Gutterman; C M McBride
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

Review 7.  Sentinel lymph node biopsy progress in surgical treatment of cancer.

Authors:  T Schulze; A Bembenek; P M Schlag
Journal:  Langenbecks Arch Surg       Date:  2004-06-09       Impact factor: 3.445

8.  Lymphatic drainage of skin to a sentinel lymph node in a feline model.

Authors:  J H Wong; L A Cagle; D L Morton
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

9.  Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic.

Authors:  D L Morton; L Wanek; J A Nizze; R M Elashoff; J H Wong
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

10.  Results of ilioinguinal dissection for stage II melanoma.

Authors:  S J Finck; A E Giuliano; B D Mann; D L Morton
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.